Showing results (2351-2360 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|June 8, 2019
A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid TumorsM Dror Michaelson, Shilpa Gupta, Neeraj Agarwal, et al.
The Oncologist|May 9, 2019
Effectiveness of EGFR-TKIs in a Patient with Lung Adenocarcinoma Harboring an EGFR-RAD51 FusionYan Guan, Zhanshuai Song, Yan Li, et al.
The Oncologist|April 13, 2019
Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung CancerLecia V Sequist, Jhanelle Elaine Gray, Wael A Harb, et al.
The Oncologist|May 18, 2019
Patient-Friendly Language to Facilitate Treatment Choice for Patients with CancerJanice Kim, Jennifer Gao, Laleh Amiri-Kordestani, et al.
The Oncologist|May 18, 2019
Safe Opioid Use, Storage, and Disposal Strategies in Cancer Pain ManagementAkhila Reddy, Maxine de la Cruz
The Oncologist|April 19, 2019
The Increasingly Complicated Approach to Rectal CancerDavid P Ryan
The Oncologist|July 5, 2019
Patterns of Symptoms Burden in Neuroendocrine Tumors: A Population-Based Analysis of Prospective Patient-Reported OutcomesJulie Hallet, Laura E Davis, Alyson L Mahar, et al.
The Oncologist|March 12, 2022
Optimism Bias in the Design of Phase III Randomized Control Trials Evaluating PD-1/PD-L1 Targeting Monoclonal AntibodiesLaith Al-Showbaki, Fahad A Almugbel, Husam A Alqaisi, et al.
The Oncologist|March 11, 2022
Real-world Treatment Patterns and Reasons for Therapy Selection in Patients with Advanced Hepatocellular Carcinoma in US Oncology PracticesAndrew J Klink, Landon Z Marshall, Abdalla Aly, et al.
The Oncologist|March 11, 2022
Impact of the Economic Status of the Patient's Country of Residence on the Outcome of Oncology Clinical TrialsSaki Nishiyama, Mamoru Narukawa
Pageof 571